To differentiate DSRCT from EWS/PNET, when the genetic information is not available, immunohistochemistry is recommended with an anti-WT1 antibody, highly specific and sensitive, that is a reliable index for the presence of the EWS-WT1 chimeric product (119). This evidence concerns the gene WT1 and desmoplastic small round cell tumor.